. Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 60?74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction
. Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 60?74 years with high risk conditions are calculated using data from the National Immunization Survey-Adult COVID Module (NIS-ACM) (https://www.cdc.gov/nis/about/)
. In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ?60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60-74 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older.?

Tags: nis-acm, iis, iqvia, vsd, nis-flu, rsv vaccination

Last updated: 2025-11-13 16:54:23+00:00